Brixadi (buprenorphine) Subcutaneous Injection, 32 mg Weekly, Prefilled Syringe 0.64 mL, Each
Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 32 mg weekly subcutaneous dose in a 0.64 mL volume, providing a convenient once-weekly administration option. It is intended for use in patients who have initiated treatment with a transmucosal buprenorphine product.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 32 mg weekly subcutaneous dose in a 0.64 mL volume, providing a convenient once-weekly administration option. It is intended for use in patients who have initiated treatment with a transmucosal buprenorphine product.
1 vendor
